Keros Therapeutics, Inc. (KROS)
11.23
+0.16
(+1.45%)
USD |
NASDAQ |
Sep 02, 16:00
11.23
0.00 (0.00%)
After-Hours: 17:53
Keros Therapeutics Net Income (TTM) : -83.16M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -83.16M |
| March 31, 2026 | -85.14M |
| December 31, 2025 | 87.01M |
| September 30, 2025 | 64.45M |
| June 30, 2025 | 18.77M |
| March 31, 2025 | 4.212M |
| December 31, 2024 | -187.35M |
| September 30, 2024 | -181.57M |
| June 30, 2024 | -168.05M |
| March 31, 2024 | -160.30M |
| December 31, 2023 | -152.99M |
| September 30, 2023 | -142.47M |
| June 30, 2023 | -126.54M |
| March 31, 2023 | -116.30M |
| Date | Value |
|---|---|
| December 31, 2022 | -104.68M |
| September 30, 2022 | -81.90M |
| June 30, 2022 | -78.69M |
| March 31, 2022 | -67.04M |
| December 31, 2021 | -58.74M |
| September 30, 2021 | -62.48M |
| June 30, 2021 | -54.22M |
| March 31, 2021 | -49.35M |
| December 31, 2020 | -45.36M |
| September 30, 2020 | -37.44M |
| June 30, 2020 | -28.95M |
| March 31, 2020 | -21.04M |
| December 31, 2019 | -12.34M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Incyte Corp. | 1.612B |
| Nurix Therapeutics, Inc. | -341.35M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| Anika Therapeutics, Inc. | -3.121M |